| 发明名称 |
NICOTINIC ATTENUATION OF CNS INFLAMMATION AND AUTOIMMUNITY |
| 摘要 |
The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof. |
| 申请公布号 |
US2014364463(A1) |
申请公布日期 |
2014.12.11 |
| 申请号 |
US201414451318 |
申请日期 |
2014.08.04 |
| 申请人 |
Dignity Health |
发明人 |
Shi Fu-Dong;Lukas Ronald J.;Vollmer Timothy |
| 分类号 |
A61K31/465;A61M5/145 |
主分类号 |
A61K31/465 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a disease in a subject, comprising:
providing a composition comprising a nicotinic receptor agent; and administering a therapeutically effective dosage of the composition to enhance the activity of a compound that treats the disease. |
| 地址 |
Phoenix AZ US |
